No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Asacol is a brand of mesalamine, an anti-inflammatory drug used to treat ulcerative colitis, a type of inflammatory bowel disease. It is a type of aminosalicylate, which works by reducing inflammation in the gastrointestinal tract. Asacol is available in both oral and rectal forms, and is usually taken two to four times a day. It is also available in combination with other drugs, such as balsalazide and sulfasalazine. Asacol is generally well-tolerated, but may cause side effects such as nausea, headache, and abdominal pain.
The Asacol market is a subset of the larger gastrointestinal drugs market, which includes a variety of medications used to treat digestive disorders. These drugs are used to treat a wide range of conditions, including irritable bowel syndrome, Crohn's disease, and ulcerative colitis. The market is highly competitive, with a number of companies offering similar products.
Some of the companies in the Asacol market include Allergan, AstraZeneca, Pfizer, and Takeda Pharmaceuticals. Other companies include AbbVie, Merck, and Novartis. Show Less Read more
